Bestrol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bestrol

Quick Facts

Property Description
Active ingredient Alprazolam
Form Tablet, Extended-Release Tablet, Oral Solution
Pharmacological class Triazolobenzodiazepine, CNS Depressant
Common use Relief of excessive worry and tension (Anxiolytic)
Origin Synthetic

What Type of Medication is Alprazolam (Bestrol)?

This medication, which contains the active pharmaceutical ingredient Alprazolam, is classified as a psychoactive medication belonging to the triazolobenzodiazepine class of drugs, a distinct subgroup of benzodiazepines. This classification places it within the broader category of Central Nervous System (CNS) depressants, substances engineered to slow down neural activity. Alprazolam is a synthetic compound, chemically manufactured, and defined as a single-ingredient product. The compound is recognized for its high-potency and effectiveness in managing acute distress states, a feature differentiating it from certain longer-acting benzodiazepine analogues. Its precise chemical structure is chemically cataloged.

Composition, Forms, and General Purpose

The core component of this medication is Alprazolam, which serves as the sole active ingredient (INN). It is available for the oral route of administration in standard tablet, extended-release tablet, and oral solution forms, offering flexibility for different patient needs. The compound is primarily utilized for its potent anxiolytic (anti-anxiety) effects. The extended-release version is specifically designed to provide consistent, all-day relief. The overall purpose of the medication is to provide relief from feelings of excessive worry and tension, a scenario where immediate symptomatic control is needed. Alprazolam's rapid onset of action is clinically recognized as key to managing acute symptoms of anxiety.

What side effects are possible with Bestrol?

Possible Side Effects and Safety Information

The official safety profile for Bestrol (Alprazolam), a triazolobenzodiazepine, is primarily structured around its documented actions as a Central Nervous System (CNS) depressant. Adverse reactions are grouped by frequency and affected organ systems, according to regulatory documents.


Frequency-Classified Adverse Reactions

The most frequently classified effects are related to CNS depression:

Classification Examples of Documented Effects
Very Common (ge 1/10) Sedation, Somnolence (Drowsiness), Depression, Ataxia (Impaired Coordination), Fatigue.
Common (ge 1/100 to <1/10) Dizziness, Headache, Memory impairment, Confusional state, Anxiety, Constipation, Dry mouth.
Uncommon (ge 1/1,000 to <1/100) Mania, Hallucination, Drug dependence, Amnesia, Aggression.

Serious Safety Risks and Time-Related Patterns

Official regulatory labeling includes warnings about serious safety risks, such as profound sedation, respiratory depression, and death when used concomitantly with opioids. There is also a documented risk of abuse, misuse, and addiction, as well as the potential for severe withdrawal syndrome (including seizures) if the medication is abruptly discontinued.

Time-related safety notes indicate that the risk of withdrawal or rebound phenomena is greater following abrupt cessation, and that a degree of tolerance to the effects may develop over repeated use.


Population-Specific Safety Considerations

The official label includes specific cautions for certain patient groups. Older adults are documented as being more susceptible to CNS-related adverse effects, such as sedation and dizziness. For patients with severe hepatic impairment, use may be contraindicated. Additionally, the label notes the potential for neonatal sedation and withdrawal symptoms in the newborn if used during the later stages of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

Bestrol (Alprazolam) overdose may present with signs of increasing central nervous system (CNS) depression, as documented in regulatory prescribing information. The officially recognized manifestations of overdose range from milder symptoms such as somnolence, confusion, ataxia (impaired coordination), and diminished reflexes to more severe physiological states.

Classification Aspect Official Regulatory Statement
Documented Manifestations Somnolence, Confusion, Ataxia, Lethargy
Severe Outcomes Respiratory Depression, Hypotension, Coma

Urgent medical attention is required for any suspected overdose. The most serious and life-threatening outcomes documented in regulatory sources include severe hypotension, respiratory depression, and coma, which necessitates immediate contact with emergency services. The risk of these severe effects is significantly increased when the medication is taken alongside alcohol or other CNS depressants, a factor explicitly warned about in regulatory labeling. Elderly patients may also exhibit increased sensitivity to overdose effects.

Official treatment approaches focus on symptomatic and supportive treatment to maintain vital functions, including cardiac and respiratory monitoring. While a specific antagonist, Flumazenil, is described in the regulatory information, its use is often cautioned against, as it carries a risk of inducing seizures. Due to the potential for severe outcomes, regulatory guidance mandates continuous hospital monitoring for patients following a known or suspected overdose.

Therapeutic Uses of Bestrol

What Bestrol Treats: Main Uses and Benefits

Bestrol is commonly used in the treatment of Generalized Anxiety Disorder (GAD) and Panic Disorder in adults.


Support for Persistent Worry and Acute Distress

This medication is applied across therapeutic domains where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms. It is considered relevant for easing symptoms that become more disruptive during flare-ups, including excessive worry and mental tension. The medication may assist with managing these symptoms that create noticeable interference with daily stability. In clinical settings, it is often used during phases where the patient experiences increased distress, such as the severe, sudden-onset fear associated with recurrent panic attacks. This provides supportive relief when symptoms interfere with routine activities.

“It is commonly used when symptoms intensify and supportive relief is needed.”


Quick Fact: Support for Mental Tension

Symptom Domain Key Benefit
Chronic Worry / GAD Contributes to easing the overall symptom load during periods of symptomatic discomfort.
Panic Attacks Supports patients during difficult episodes of high-intensity fear.
Functional Strain Assists with maintaining functional stability when symptoms become temporarily overwhelming.

Regulatory References

  1. U.S. National Library of Medicine (NIH) DailyMed Information

Eligibility and Restrictions for Use

Eligibility for Bestrol (Alprazolam) is Defined by Regulatory Status

Official regulatory documents define specific populations who are eligible for Bestrol and those who are prohibited or require special consideration.

Classification Population/Condition
Absolutely Contraindicated Hypersensitivity to alprazolam or other benzodiazepines.
Acute narrow-angle glaucoma.
Severe hepatic insufficiency (severe liver disease).
Patients taking potent CYP3A inhibitors, such as ketoconazole or itraconazole.
Myasthenia gravis, severe respiratory insufficiency, or sleep apnoea syndrome.
Use Not Established Children and adolescents under 18 years of age.
Not Recommended Pregnant women (risk of fetal harm and neonatal withdrawal syndrome).
Nursing mothers (excreted in human milk).
Conditional Use Required Elderly patients (65 years and older).
Patients with mild to moderate hepatic or renal impairment.
Individuals with a history of alcohol or drug abuse or those with depressive disorders.

Regulatory authorities restrict use to adults for whom the drug is indicated. All other populations are subject to strict prohibitions or conditional use rules, such as special caution in patients with existing lung or breathing problems.

What should I know about interactions with other medicines?

Bestrol Interactions with other medicines and products

Interactions with Bestrol (Alprazolam) are governed by two critical axes: additive effects on the central nervous system (CNS) and alterations to the drug's metabolic pathway. This information is based solely on authoritative government regulatory documents.

Interaction Type Interacting Substances/Classes Regulatory Constraint
Pharmacodynamic Opioids, Alcohol, other CNS Depressants Boxed Warning for Opioids due to profound sedation and respiratory depression risk. Co-ingestion of alcohol is restricted.
Pharmacokinetic Strong CYP3A Inhibitors Formally Contraindicated (e.g., Ketoconazole, Itraconazole) due to severely increased Alprazolam plasma exposure (up to approx 4-fold AUC increase).

Alprazolam is primarily cleared by the Cytochrome P450 3A (CYP3A) enzyme system. This enzyme is the basis for most pharmacokinetic interactions. Other potent inhibitors (e.g., Fluvoxamine, Nefazodone) also significantly increase drug exposure. Conversely, CYP3A inducers, such as Carbamazepine, accelerate drug clearance, leading to lower plasma concentrations and the potential for reduced efficacy.

Food and herbal products also interact; for instance, Grapefruit juice is officially restricted due to its inhibitory effect on CYP3A. The official label further notes a population-specific pharmacokinetic change: the elimination half-life is substantially prolonged in patients with alcoholic liver disease, which necessitates consideration for altered drug clearance.

Mechanism of Action

Bestrol (Diethylstilbestrol) functions as a synthetic nonsteroidal estrogen analog. Its primary biological targets are the intracellular estrogen receptors (ERs), specifically acting as an agonist at both the Estrogen Receptor alpha (ERalpha) and Estrogen Receptor beta (ERbeta) subtypes.

Following passive diffusion across the cell membrane, Bestrol binds to and activates the cytoplasmic ERs. The activated receptor-ligand complex dimerizes and translocates into the cell nucleus, where it binds to specific Estrogen Response Elements (EREs) on the DNA. This interaction modulates the transcription of numerous target genes, initiating the synthesis of corresponding proteins.

Downstream cascades involve the up-regulation of hepatic synthesis of plasma proteins, including sex hormone-binding globulin (SHBG), and the suppression of pituitary gonadotropin release, particularly follicle-stimulating hormone (FSH), via feedback loops on the hypothalamic-pituitary-gonadal (HPG) axis. System-level physiological modulation thus includes a significant alteration of the endocrine environment by suppressing endogenous gonadotropin secretion and modifying circulating free hormone levels.

Dosage and Administration Information

How to Use Bestrol

Bestrol (Alprazolam) is administered solely via the oral route, available in several formulations including the immediate-release (IR) tablet, the extended-release (ER) tablet, an oral solution, and an orally disintegrating tablet. The IR tablet and oral solution can be taken without regard to food. Procedural instructions require that the ER tablet must be swallowed whole and must not be crushed, chewed, or divided, to maintain its controlled-release properties.


Standard Dosing Patterns

The frequency and starting dose are dependent on the specific formulation and indication, as clinically established.

Indication / Form Initial Daily Dose (Adults) Frequency Max Labeled Daily Dose
GAD (IR Tablet) 0.75 mg (0.25 mg TID) Three times daily 4 mg
Panic Disorder (ER Tablet) 0.5 mg to 1 mg Once daily 10 mg

Dosage adjustments are made gradually, with increases limited to no more than 1 mg per day, occurring at intervals of three to four days. If a dose is missed, it should be skipped if it is almost time for the next scheduled dose; patients are instructed not to double the dose.


Procedural Constraints and Duration

For older or debilitated adults, the initial daily dose is lower, starting at 0.5 mg to 0.75 mg total per day in divided doses (IR) or 0.5 mg once daily (ER). The medication is not recommended for pediatric patients. Clinical trials regarding Generalized Anxiety Disorder were limited to four months, and total treatment length for anxiety should generally not exceed 12 weeks including the reduction period. When discontinuing treatment, the dose must be reduced gradually. Standard protocols for tapering mandate that the dosage be decreased by no more than 0.5 mg every three days to ensure a controlled reduction.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bestrol (Alprazolam)


Evidence for Use in Panic Disorder

The primary research base for the use of Bestrol in Panic Disorder is built upon a number of short-term, randomized controlled trials (RCTs) that compare the medicine to an inactive substance (placebo) or sometimes to other psychiatric medications. The research focused on adult outpatients experiencing conditions characterized by fluctuating or episodic manifestations, such as panic attacks. Researchers monitored specific outcomes related to episodic or acute changes, such as the frequency and intensity of panic attacks.

In these acute research settings, which typically lasted between four and ten weeks, studies reported that the use of Bestrol was observed in studies where researchers measured lower mean panic attack frequency scores compared to the placebo groups. Studies also explored outcomes related to daily functioning or activity level, as well as global scales used to assess overall illness severity. Systematic reviews have documented that, when compared with other medicines in the same drug class, the findings related to measured symptom changes were often not significantly different.


Evidence for Use in Generalized Anxiety Disorder (GAD)

Research into the use of Bestrol for Generalized Anxiety Disorder (GAD) also primarily consists of short-term randomized controlled trials. These studies focused on populations experiencing conditions involving periods of heightened symptoms, such as excessive worry and mental tension. The main research goals were to measure changes in anxiety symptom intensity using standardized rating scales and to examine patient-reported outcomes describing perceived discomfort.

These studies, which typically had follow-up durations of up to four months, reported measurements showing lower scores on anxiety severity scales in the observed populations. Research examined changes measured during the study period in outcomes related to physiological strain or stress. However, research has explored how symptoms evolved only over defined time intervals, with most core controlled studies not extending beyond four months.


Long-Term Evidence and Maintenance of Effect

A crucial aspect of the research landscape is the duration of the studies. Most of the core clinical evaluation data is based on short-term follow-up durations. This means that while research provides insight into short-term changes, there is limited information for long-term outcomes beyond the initial treatment phase for both Panic Disorder and GAD. The long-term study outcomes are not fully established by controlled trials. Researchers and regulators note that there is a lack of controlled long-term research that monitors outcomes, such as the maintenance of symptom patterns, over extended periods.


Key Uncertainties and Research Gaps

One significant gap is the short duration of the controlled trials, which means that the long-term clinical outcomes and symptom patterns over extended periods are not well characterized. Additionally, concerns have been noted in regulatory reviews regarding potential publication bias, suggesting that findings were mixed across all conducted studies. This indicates that evidence quality varies across studies, contributing to the limitations. Study results reflect the specific conditions under which they were conducted and describe group patterns, not personal outcomes.

Key Studies & References

  1. Clinical Guideline: Generalised anxiety disorder and panic disorder in adults: management

Frequently Asked Questions (FAQ)

Common questions about Bestrol (FAQ)

Q: Is Bestrol the brand name or the generic name of the medicine?

A: Bestrol is the brand name used for the medicine, and Alprazolam is the active pharmaceutical ingredient (API), which is the generic name. Official regulatory documents list Alprazolam as the single active ingredient in this medication, regardless of the brand used.

Q: How quickly can I expect to notice the full effects of Bestrol?

A: Official information indicates that Alprazolam is rapidly absorbed after being taken by mouth. Peak concentrations of the medicine in the blood typically occur within 1 to 2 hours. While this pharmacokinetic data points to a rapid absorption profile, the time to experience the medicine's intended effects may vary between individuals.

Q: Can Bestrol interact with common pain relievers like ibuprofen or acetaminophen?

A: Regulatory documents primarily focus on interactions with opioids, alcohol, and certain metabolism-blocking drugs. Specific interactions with common nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or pain relievers like acetaminophen are not generally highlighted in the official labeling. Official patient information generally recommends that a healthcare provider be aware of all over-the-counter medicines used due to the potential for compounded CNS depressant effects.

Q: Are there any vitamins or herbal supplements that should be avoided while taking Bestrol?

A: Official product information states that the co-ingestion of Grapefruit juice is restricted because it may interfere with how the body processes Alprazolam. Patients are generally advised to inform their healthcare provider about all vitamins, supplements, or herbal products they are taking. This is necessary because some of these substances can affect the enzymes that clear Alprazolam from the body.

Q: Is it possible for Bestrol to affect the results of laboratory blood tests?

A: Regulatory information indicates that interactions between benzodiazepines, the class Bestrol belongs to, and common laboratory tests have been occasionally reported. Alprazolam is noted to have a weak uricosuric effect; however, acute renal failure has not been directly attributed to its use in regulatory summaries.

Q: If I am taking Bestrol, can I still donate blood?

A: While the medication itself may not be a direct factor, official guidance from regulatory and blood service authorities states that the underlying medical condition for which Bestrol is prescribed might prevent a person from donating blood. A person's eligibility to donate blood is generally determined by official blood service guidelines, which consider overall medical history and current health status, including the underlying condition for which the medicine is taken.

Q: Does Bestrol need to be taken at the exact same time every day?

A: Official administration instructions specify that the medicine should be taken at a certain frequency, such as once daily or three times daily. The times of daily administration should be distributed as evenly as possible. Regulatory documents do not typically mandate taking the dose at the exact same minute every day.

Q: What should be done if I experience a very rare but serious side effect?

A: Official patient information states that severe adverse effects, such as marked drowsiness, difficulty breathing, or changes in mood, should be reported to a healthcare professional immediately or addressed by seeking emergency medical attention.

Q: Can Bestrol be taken by people with a history of heart problems?

A: Official regulatory documents require that precautions be taken for individuals with underlying medical conditions. While a history of heart failure is not listed as an absolute contraindication, the effects of a CNS depressant may require special consideration by the healthcare provider overseeing treatment.

Q: Why do official documents mention specific safety monitoring tests for Bestrol?

A: Monitoring tests are often noted in official documents for use with specific patient groups, such as those with impaired liver or kidney function. This is because these conditions may alter the way the body clears the medicine, potentially leading to varied concentrations in the system.

Q: Is it common for people to stop taking Bestrol due to side effects?

A: Regulatory documents list the frequency of adverse reactions but do not typically provide specific rates of discontinuation from clinical trials. However, effects like sedation, dizziness, and dependence are highlighted as key safety risks in the official safety profile.

Q: How long does Bestrol stay in the system after the last dose?

A: The mean plasma elimination half-life of Alprazolam is reported to be about 11.2 hours in healthy adults. The term half-life describes the period needed for the medicine's concentration in the body to be reduced by half. This period can be significantly prolonged in specific populations, such as older adults or people with liver impairment.

Q: Are there any lifestyle restrictions (like driving or operating machinery) associated with Bestrol?

A: Official patient information cautions that, due to the CNS depressant effects which may cause drowsiness or impaired coordination, activities requiring mental alertness, such as driving or operating heavy machinery, should be avoided until the medicine's effects are fully known.

Q: Are there specific over-the-counter cold and flu medications that interact with Bestrol?

A: The official label warns against taking Bestrol with other Central Nervous System (CNS) depressants. Combining Bestrol with other CNS depressants may increase the risk of amplified effects such as sedation and respiratory depression.

Q: Is the effectiveness of Bestrol influenced by the patient's diet?

A: Official product information notes that the immediate-release tablet can be taken without regard to food. However, the effectiveness is known to be influenced by Grapefruit juice, which is restricted because it affects the metabolism of the medicine. Beyond the restriction on grapefruit products, no other specific food-only interactions are generally highlighted in the official product information.

Q: Is it okay to switch between brand and generic versions of Bestrol?

A: Regulatory guidance requires that generic versions contain the exact same active ingredient and demonstrate bioequivalence to the brand-name drug. Regulatory requirements indicate that generic products should be used unless a healthcare provider specifies that they should not be.

Q: Can Bestrol affect the effectiveness of birth control pills?

A: According to the available regulatory data, there is no documented pharmacokinetic interaction between Alprazolam and most hormonal contraceptives. Regulatory data does not typically indicate a significant pharmacokinetic interaction with these products.

Q: Is Bestrol generally appropriate for older adults (seniors)?

A: Use is generally permitted, but official regulatory guidance requires special caution for older adults (65 years and older). For this population, the risk of CNS-related adverse effects like oversedation and impaired coordination is noted to be greater. Official guidance notes that the initial dose needs to be set lower than the standard adult dose.

Q: Has there been any research on Bestrol's use in pediatric patients?

A: Official regulatory labels state that the use of Bestrol in children and adolescents has not been established. Pharmacokinetic data and effectiveness have not been sufficiently studied or documented in this population. This lack of established safety and effectiveness results in the medicine being not recommended for use in individuals under 18 years of age.

Q: Can Bestrol affect sleep patterns (making it harder to fall asleep or causing vivid dreams)?

A: Official adverse reaction lists commonly include CNS effects such as somnolence (drowsiness) and fatigue. Although the medicine is intended to manage anxiety, its effects as a CNS depressant can modulate sleep architecture, which may lead to various changes in sleep patterns.

Q: How does Bestrol affect the liver or kidney function, according to official reports?

A: Bestrol is processed primarily by the liver. Use is contraindicated in patients with severe hepatic impairment (severe liver disease) because the body cannot clear the medicine effectively. For individuals with mild-to-moderate liver or kidney impairment, the dose may need careful consideration due to the potential for altered elimination.

Q: What happens to Bestrol in the body after it is taken (high-level explanation of metabolism)?

A: Once taken, Bestrol (Alprazolam) is readily absorbed into the bloodstream. It is then extensively broken down by a specific enzyme system in the liver, known as CYP3A4, into two major inactive compounds. These compounds and other residual medicine are eventually excreted primarily in the urine.

How should Bestrol be stored and disposed of?

How to Store and Dispose of Bestrol?

The storage and disposal requirements for Bestrol (Alprazolam) are officially defined in regulatory labeling to ensure product stability and safety.

Required Storage Conditions

Condition Requirement
Temperature Store at Controlled Room Temperature, between 20°C and 25°C (68°F and 77°F).
Heat/Light Avoid excessive heat; storage excursions up to 30°C (86°F) are permitted.
Container Store in a tightly closed container to prevent environmental exposure.
Child Safety Keep this medicine out of the reach of children.

Disposal Instructions

Official instructions require the disposal of unused, unneeded, or expired medication as directed by a healthcare professional. Disposal should be carried out using a drug take-back program where available, consistent with national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bestrol found in:

A-Z Index: